Philip Bejon
Director Modernising Medical Microbiology
I was Director of the KEMRI-Wellcome Trust Research Programme up to January 2024, and was based in Kenya for 10 years. I am now based in Oxford, as Director of the Modernising Medical Microbiology Unit, where I work on antimicrobial resistance, bone infection, and pathogen genomics. I continue to work with colleagues based in Kenya on controlled human malaria infection studies, and on evaluations of malaria vaccines in the field, on validating definitions of severe malaria, studies of naturally acquired immunity to malaria, evaluations of Ebola and Yellow Fever vaccines, and on the epidemiology and immunology of COVID in Kenya.
Visit Philip's profile page for Modernising Medical Microbiology
Recent publications
-
Comparative performance of the InBios SCoV-2 DetectTM IgG ELISA and the in-house KWTRP ELISA in detecting SARS-CoV-2 spike IgG antibodies in Kenyan populations
Kutima B. et al, (2025), Wellcome Open Research, 9, 349 - 349
-
Uncovering the genetic diversity of the malaria parasite antigen MSP2 across Sub-Saharan Africa
Zerebinski J. et al, (2025)
-
Pf8: an open dataset of Plasmodium falciparum genome variation in 33,325 worldwide samples
Abdel Hamid MM. et al, (2025), Wellcome Open Research, 10, 325 - 325
-
Establishing laboratory reference ranges for haematological and biochemical blood parameters in adults and children in Kilifi, Kenya
Downs LO. et al, (2025), Wellcome Open Research, 10, 312 - 312
-
A pragmatic randomized controlled trial of standard care versus corticosteroids plus standard care for treatment of pneumonia in adults admitted to Kenyan hospitals (SONIA)
Lucinde R. et al, (2025), Wellcome Open Research, 7, 269 - 269